Journal Information
Vol. 42. Issue S1.
Pages 37 (October 2020)
Share
Share
Download PDF
More article options
Vol. 42. Issue S1.
Pages 37 (October 2020)
PP 04
Open Access
Postdural puncture superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia
Visits
1445
A. Ozturkmen1, E. Gulturk1, o. Yildiz2, F. Hindilerden1,*
1 University of Health Sciences Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Division of Hematology, İstanbul, Turkey
2 University of Health Sciences Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Department of Radiology, İstanbul, Turkey
This item has received

Under a Creative Commons license
Article information
Full Text

Objective: Superior sagittal sinus thrombosis (SSST) during the course of acute lymphoblastic leukemia (ALL) may arise during or even after treatment. Majority of the cases are either directly attributed to ALL or considered as a consequence of using chemotherapy agents including prednisone, vincristine, cytarabine and especially l-Asparaginase. Post-lumbar puncture intracranial hypotension is a rarely encountered cause of SSST in ALL.

Case report: A 27-year-old man was admitted with fatigue and following bone marrow aspiration and biopsy, he was diagnosed as having B-ALL. He received HyperCVAD regimen as remission induction therapy, which included doxorubicine, vincristine and cyclophosphamide, dexamethasone and intrathecal administration of methotrexate. Cranial computerized tomography (CT) prior to intrathecal methotrexate was normal. Cerebrospinal fluid analysis was acellular and showed no ALL infiltration. He complained of mild postural headache intrathecal treatment. Eight days after intrathecal administration of methotrexate on day 13 of HyperCVAD, he complained of newly developing non-postural headache and vomiting.

Methodology: At the time of symptoms, complete blood count showed the following: WBC: 5480/uL, Hgb: 12.3g/dL and PLT: 148,000/uL. Coagulation profile studies showed prothrombin time of 13s, partial thromboplastin time (PTT) of 30.9s, and normal concentrations of fibrinogen. Neurologic examination including evaluation of his mental status, sensory, motor, and reflex functions of his extremities. Coronal plane contrast enhanced T1-weighted MRİ demonstrated a nonenhancing superior sagittal sinus with the empty delta sign, compatible with a diagnosis of SSVT. Enoxaparin 2×1mg/kg was initiated. Platelet transfusions were given to keep platelet count over 50,000/uL during the course of anticoagulant therapy.

Results: SSST in the context of ALL has been ascribed to lymphoblastic infiltration of the superior sagittal sinus wall or to the chemotherapeutic agents used. l-Asparaginase decreases plasma antithrombin, plasminogen, and fibrinogen concentrations while prednisone may increase the levels of factor VIII. These hemostatic changes may predispose to thrombosis, especially in the setting of the turbulent flow in the superior sagittal sinus. Our patient harbored none of the aferomentioned risk factors except for the use of corticosteroids. Any cause of intracranial hypotension, which induces a downward shift and traction of the brain, may disrupt the veins/sinus and hence may lead to venous dilatation and thrombosis.

Conclusion: Our patient most probably developed intracranial hypotension due to lumbar puncture, which resulted in SSST. The possibility of a dural venous thrombosis should be suspected in patients with ALL who had treatment with l-asparaginase and prednisone. However, SSST thrombosis should also be an important consideration in patients with dural puncture who report a changing pattern of their headache (postural headache becoming nonpostural in character) and severe nausea and vomiting.

Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools